Pharmidex delighted to meet with US Congressional Representative Scott Peters
October 28, 2017
Pharmidex delighted to meet with Congressional Representative Scott Peters and a delegation of San Diego, California's top business, civic and academic leaders in London.
17 October 2017 Pharmidex was delighted to be invited to a reception with United States Congressional Representative Scott Peters and a delegation of San Diego, California's top business, civic and academic leaders in London.
With thriving respective tech scenes, growing biotech industries and home to some of the world's best universities, London and San Diego are privileged to be known as two of the world's "smartest cities". Pharmidex has had a long interest in California as our first out of UK business development office was based at Sorrento Valley in San Diego.
Early-stage innovators based in Scotland have access to a significant opportunity to advance their programs toward ProofOfConcept, with an additional £2.85M fund from the Scottish Government aimed at supporting early development and enabling further investment. 🗓️ Deadline: 8th May At Pharmidex , we work alongside our partners to generate robust, translational data that supports confident decision-making across early discovery and preclinical development. Our capabilities include: TargetExpression ModeOfActionStudies TargetEngagement HitIdentification ADME and PK profiling If you are preparing an application and require scientific input or timely quotations, we would be pleased to support your programme. 🔗 https://lnkd.in/eZ6vVjgN
We’re pleased to introduce the Pharmidex Senior Management Team (SMT), bringing together expertise across drug discovery, bioanalysis, DMPK, and translational science: 🔹 Alix Hampson 🔹 Dr Mansoor Chishty 🔹 Prof Mo Alavijeh (FRSC, FRSM) 🔹 Dr Martin Barrett 🔹 Dr Stephen Mitchell 🔹 Ash Alavijeh Collectively, the team brings 150+ years of combined experience, supporting programmes from discovery through to the clinic and beyond. We’ve also seen firsthand how similar pieces, in the hands of our 400+ innovative clients, can be combined to unlock real impact for patients. To mark the occasion, we’ve reimagined our SMT in LEGO style 🧱 Much like LEGO: • Great things are built step by step • Every piece has a purpose • The best outcomes come from creativity, collaboration, and continuous evolution At Pharmidex, it’s about bringing the right pieces together, to build smarter solutions and better outcomes.
The success of your research starts with the right model, at the right time. At Pharmidex, we deliver tailored GA breeding solutions combining expert colony management, flexible study design, and rigorous quality control. Backed by AAALAC-accredited facilities and a strong commitment to the 3Rs, we ensure reliable, study-ready models with full traceability. From breeding strategy and genotyping to scalable capacity and flexible timelines, we act as an extension of your team, helping accelerate your research with confidence. 🔬 The right models. When you need them. 🚀 Flexible. Reliable. Research-focused. Let’s build your next breeding strategy.
